XML 70 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Operating activities:    
Net income (loss) $ 90,862 $ (4,838,205)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 1,955,701 3,956,384
Stock based compensation 300,413 386,864
Deferred income taxes (158,699) 0
Corporate headquarters relocation costs, net of reimbursements 0 0
Amortization of financing fees 20,833 0
Adjustment of European liabilities related to discontinued operations (306,036) (53,021)
Provision for doubtful accounts 0 46,967
Other, net 2,830 0
Change in operating assets and liabilities, net of acquisition:    
Accounts receivable and unbilled revenue 724,454 1,959,018
Prepaid expenses and other assets (208,521) 23,138
Accounts payable (2,311,397) 1,449,942
Accrued expenses and other liabilities 722,267 (3,220,248)
Other, net (170,088) (13,744)
Net cash provided by (used in) operating activities 662,619 (302,905)
Investing activities:    
Purchases of equipment and capitalized development costs (681,231) (628,600)
Grant funds received for equipment and office construction 360,812 0
Acquisition of Vertro, Inc., net of stock issuance costs 0 2,424,383
Purchase of names database and bundled downloads 0 (2,184,076)
Net cash used in investing activities (320,419) (388,293)
Financing activities:    
Proceeds from revolving credit line 3,500,000 3,000,000
Payments on revolving credit line (3,717,309) 0
Payments on term note payable and capital leases (692,908) (3,550,658)
Proceeds from term note payable 0 5,000,000
Prepaid financing fees and other 37,600 0
Deposit to collateralize letter of credit 301,158 (475,000)
Net cash (used in) provided by financing activities (571,459) 3,974,342
Effect of exchange rate changes (124) (5,579)
Net change – cash (229,383) 3,277,565
Cash, beginning of period 3,381,018 4,413
Cash, end of period 3,151,635 3,281,978
Supplemental information:    
Interest paid 173,074 238,501
Issuance of stock as settlement of deferred compensation 0 915,750
Restricted advances on term note payable $ 0 $ 475,000